Compare EPR Properties (EPR) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EPR Properties vs Neurocrine Biosciences Inc — how do they compare? EPR Properties trades at $59.8 (market cap $4.58B), while Neurocrine Biosciences Inc trades at $151.61 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.6× EPR Properties's market cap, and EPR Properties pays a 6.22% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| EPR | NBIX | |
|---|---|---|
Market Cap | $4.58B | $16.46B |
Sector | Real Estate | Health |
52-Week High | $64.32 | $185.50 |
52-Week Low | $48.71 | $123.10 |
Enterprise Value | $8.09B | $16.48B |
Dividend Yield | 6.22% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
